Lv2
110 积分 2024-09-19 加入
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management
2天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
4天前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
4天前
已完结
Drug-induced liver injury
7天前
已完结
Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug‐induced liver injury: A phase II trial
8天前
已完结
The chemical profile of Fubai Chrysanthemum (Fubaiju) and its mechanism in preventing cataract based on ultrahigh‐performance liquid chromatography coupled with mass spectrometry and network pharmacology
22天前
已完结
Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
24天前
已完结
Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug‐induced liver injury: A phase II trial
24天前
已完结
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis
1个月前
已完结
Drug-induced liver injury
1个月前
已完结
皖公网安备34019202002308
